
Relidrin 2.5mg Tablet
Marketer
Reliance Lifecare Pvt Ltd
Salt Composition
Procyclidine (2.5mg)
Overview Relidrin 2.5mg Tablet
Parkinson's disease and medication-induced movement disorders are treated with the prescription medication, 2.5mg Relidrin tablets. These tablets enhance muscle control and alleviate muscle rigidity, promoting easier movement. To minimize side effects, take Relidrin 2.5mg tablets with food, consistently at the same time daily, maintaining a stable drug level. Follow your doctor's prescribed dosage and duration; if a dose is missed, take it immediately upon recollection. Complete the entire treatment course, even if symptoms improve; never discontinue use abruptly without consulting your doctor, as this may worsen symptoms. Common side effects include pupil dilation, blurred vision, lightheadedness, nausea, vomiting, upper abdominal pain, and constipation. Dizziness is possible; avoid driving or tasks requiring concentration until its effects are known. Dry mouth is frequent; counter this with regular mouth rinsing, good oral hygiene, and increased fluid intake. Contact lenses should be avoided due to potential dry eye. Inform your doctor about glaucoma or urinary difficulties. Before taking Relidrin 2.5mg tablets, disclose any history of heart conditions, urinary problems, liver or kidney disease, and all other medications you are currently taking for a thorough assessment of potential interactions. Pregnant or breastfeeding women should seek medical counsel before beginning treatment.
Uses of Relidrin 2.5mg Tablet
Movement disorders resulting from Parkinson's disease or medication
Major Benefits of Relidrin 2.5mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take the Relidrin 2.5mg Tablet with a meal.
Common Side effects of Relidrin 2.5mg Tablet:
- Dryness in mouth
- Nausea
- Vomiting
- Constipation
- Blurred vision
- Dizziness
- Lightheadedness
- Dilatation of pupil
- Epigastric pain
How to use Relidrin 2.5mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the 2.5mg Relidrin tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
How Relidrin 2.5mg Tablet works:
MyoFlex 2.5mg tablets offer muscle relaxation by modulating excessive acetylcholine levels in the brain. This action enhances motor control and alleviates muscle rigidity. Beneficial for Parkinson's disease patients, it improves mobility and natural movement by reducing stiffness and enhancing muscle control. Additionally, it addresses drug-induced movement disorders, such as akathisia, involuntary movements, and muscle spasms.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Relidrin 2.5mg tablets and alcohol may lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Using Relidrin 2.5mg tablets during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCAUTION
Lactation should be temporarily discontinued while a mother is taking Relidrin 2.5mg tablets. Breastfeeding may resume only after treatment concludes and the medication is fully cleared from the maternal system.
DrivingUNSAFE
Taking a 2.5mg Relidrin tablet might cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Individuals with kidney impairment should exercise caution when using Relidrin 2.5mg tablets. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Relidrin 2.5mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Relidrin 2.5mg Tablet :
NA
Facts to Know About Relidrin 2.5mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Aralkyl Amine Derivative |
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
| Actions | Centrally acting anticholinergic |
